Ontario investors will have access to two new labour-sponsored investment funds focused on the health sciences sector in the new year.

The CMDF Early Stage Fund and the CMDF Venture Fund will complement the successful Canadian Medical Discoveries Fund , offering investors a new family of funds, each focused on investing in businesses at different stages of development. Like CMDF, the funds will be 100% RSP-eligible and give investors access to a tax credit of up to 35%.

“The funds are new, but the focus remains the same: achieving long-term capital growth through investments in the fast-growing Canadian health sciences sector,” said Murray Douglas, president of Talvest Fund Management, which will market the new funds. “With a family of three Canadian Medical Discoveries funds, we look forward to offering new choices for Ontario investors.”

The same team that has guided the Canadian Medical Discoveries Fund since its inception will lead the new funds. Dr. Calvin Stiller will serve as chairman and CEO of the funds’ manager, Medical Discoveries Management Corporation. MDS Capital Corp., the largest shareholder in the manager, will provide management services for the funds.

Ontario residents will have a choice of three funds in the Canadian Medical Discoveries fund family.

The CMDF Early Stage Fund will emphasize investing in health science businesses in the earlier stages of development.

The CMDF Venture Fund will focus primarily on health sciences businesses in the later stages of development.

The Canadian Medical Discoveries Fund invests in health sciences businesses at all stages of development.